(Q53437174)

14 May 2018

title

To what extent can we explain time trade-off values from other information about respondents? (English)

1 reference

14 May 2018

author

Jennifer Roberts

series ordinal

2

1 reference

14 May 2018

author name string

Paul Dolan

series ordinal

1

1 reference

14 May 2018

language of work or name

English

0 references

publication date

1 March 2002

1 reference

14 May 2018

Social Science and Medicine

published in

1 reference

14 May 2018

volume

54

1 reference

14 May 2018

issue

6

1 reference

14 May 2018

page(s)

919-929

1 reference

14 May 2018

A review of the use of health status measures in economic evaluation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2801%2900066-1

7 January 2021

EuroQol: the current state of play

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2801%2900066-1

7 January 2021

The effect of experience of illness on health state valuations

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2801%2900066-1

7 January 2021

Modeling valuations for EuroQol health states

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2801%2900066-1

7 January 2021

Whose preferences count?

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2801%2900066-1

7 January 2021

Effect of age on health state valuations.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2801%2900066-1

7 January 2021

The time trade-off method: results from a general population study.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2801%2900066-1

7 January 2021

Valuing health states: a comparison of methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2801%2900066-1

7 January 2021

The time trade-off: a note on the effect of lifetime reallocation of consumption and discounting

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2801%2900066-1

7 January 2021

Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2801%2900066-1

7 January 2021

The effect of sophistication on ratio- and discriminative scales.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2801%2900066-1

7 January 2021

Methodology for measuring health-state preferences--III: Population and context effects

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2801%2900066-1

7 January 2021

Large-scale health outcomes evaluation: how should quality of life be measured? Part I--Calibration of a brief questionnaire and a search for preference subgroups.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2801%2900066-1

7 January 2021

Describing Health States

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2801%2900066-1

7 January 2021

Statistical versus quantitative significance in the socioeconomic evaluation of medicines

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2801%2900066-1

7 January 2021

Measuring preferences for health states worse than death.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2801%2900066-1

7 January 2021

Cost utility analysis: what should be measured?

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2801%2900066-1

7 January 2021

Valuing health status using VAS and TTO: what lies behind the numbers?

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2801%2900066-1

7 January 2021

10.1016/S0277-9536(01)00066-1

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018